Noticias y Actividades de Fennec Pharma

Fennec Pharma es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

Fennec Pharma es una empresa que cotiza bajo el símbolo de cotización FENC (US).

Ver el organigrama con sus 17 ejecutivos principales

Biografías más buscadas en Fennec Pharma

• Jeffrey Hackman, Chief Executive Officer and Director
• Khalid Islam, Chairman of the Board
• Jodi Cook, Director

Recientes movimientos de ejecutivos en Fennec Pharma

• Rostislav Raykov, Director, está a punto de jubilarse  (noticia publicada el 29 de abril de 2026).

Crear su alerta
para seguir los movimientos de los ejecutivos en Fennec Pharma.

Fennec Pharma tiene 2.428 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).

Popular M&A news in Biotecnología

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado el 17 de julio de 2026).
• GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado el 15 de julio de 2026).

Otros contactos sugeridos en el sector Biotecnología

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer en Inceptive
• Jan Van de Winkel - President and Chief Executive Officer en Genmab
• Robert Gould - Board Member en Fulcrum Therapeutics

Saber más sobre el sector Biotecnología

Últimos comunicados de prensa de Fennec Pharma

• Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | Fennec Pharmaceuticals Inc.
• Fennec Announces Results of Annual Meeting | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 | Fennec Pharmaceuticals Inc.
• View more press releases Close

Redes sociales sobre Fennec Pharma

• Fennec Pharma en Wikipedia, Google News y Yahoo Finance
• Fennec Pharma en LinkedIn, Twitter y YouTube